Financial Highlights - Hilltop Holdings' Q1 2025 net income available to common stockholders was $35784000, resulting in diluted EPS of $06[5] - The company's Q1 2025 pre-tax income was $401 million[5] - Q1 2025 total revenue reached $1085 million[5] - Net revenue declined by $83 million from Q1 2024 to Q1 2025, influenced by lower revenue in Structured Finance and Fixed Income, partially offset by higher revenue in Public Finance and Wealth Management[5] - Hilltop Securities generated pre-tax income of $92 million in Q1 2025[5] Banking Performance (PlainsCapital Bank) - PlainsCapital Bank's Q1 2025 pre-tax income was $401 million[5] - The bank's net interest margin was 297% in Q1 2025[64] - PlainsCapital Bank's efficiency ratio was 512% in Q1 2025[63] Mortgage Origination (PrimeLending) - PrimeLending's mortgage origination volume was $17 billion in Q1 2025, consistent with Q1 2024[5, 65] - The reported gain on sale for PrimeLending was 224 basis points[29] Capital Management - During Q1 2025, Hilltop returned $449 million to stockholders through dividends and share repurchases[9] - $116 million in dividends[9] - $333 million in share repurchases[9] - Tangible book value per share increased from $3371 on December 31, 2024, to $3429 on March 31, 2025[7] Asset Quality - The allowance for credit losses (ACL) to total loans held for investment (HFI) was 133% as of March 31, 2025[14] - Non-performing assets (NPAs) totaled $89159000, representing 117% of total bank loans plus OREO[48]

Financial Performance - The company's Q1 2025 realized gold price was $2,891 per ounce, compared to $2,062 per ounce in Q1 2024[21] - Adjusted EBITDA increased to $1590 million in Q1 2025 from $929 million in Q1 2024[21] - Net debt was reduced to $5 million at the end of Q1 2025[17, 29, 34] - The company returned approximately $251 million directly to shareholders in Q1 2025[17] - Free cash flow was $594 million in Q1 2025, compared to $396 million in Q1 2024[21] Operational Highlights - Gold production in Q1 2025 was 874 koz, slightly lower than the 879 koz produced in Q1 2024[15, 21] - Total cash costs were $903 per ounce in Q1 2025, compared to $901 per ounce in Q1 2024[21] - All-in sustaining costs (AISC) were $1,183 per ounce in Q1 2025, compared to $1,190 per ounce in Q1 2024[21] - The company is well-positioned to achieve its 2025 gold production guidance of 3300 koz to 3500 koz[15] Sustainability - The company's global GHG intensity is under the industry average at 038t CO2e/oz[19] - Approximately $11 million was donated and sponsored to local organizations, and approximately $19 billion was spent on local goods and services, of which approximately $1 billion went to Indigenous businesses[20]

Investor Presentation Delivering therapy where it matters® March 2025 © RenovoRx, Inc. All rights reserved. NASDAQ | RNXT Cautionary Note Regarding Forward-Looking Statements This presentation and statements of the Company's management made in connection therewith contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding (i) the potential of RenovoCath® or TAMP ...

Financial Performance - Q1 2025 - Total Adjusted EBITDA reached $328 million, a $34 million increase compared to Q4 2024[6] - Net sales increased to $1.763 billion in Q1 2025 from $1.708 billion in Q4 2024[8] - Net earnings before special items were $83 million in Q1 2025, compared to $81 million in Q4 2024[8] - Diluted EPS before special items remained constant at $0.11 in both Q4 2024 and Q1 2025[8] Segment Performance - Q1 2025 - Timberlands Adjusted EBITDA increased to $167 million in Q1 2025, up from $126 million in Q4 2024[6] - Real Estate, Energy & Natural Resources (ENR) Adjusted EBITDA increased to $82 million in Q1 2025, compared to $76 million in Q4 2024[6] - Wood Products Adjusted EBITDA remained stable at $161 million in both Q4 2024 and Q1 2025[6] - Unallocated items resulted in a charge of $82 million to Adjusted EBITDA in Q1 2025, compared to a charge of $69 million in Q4 2024[6] Timberlands Key Drivers - Western Timberlands Adjusted EBITDA increased to $95 million in Q1 2025 from $53 million in Q4 2024, driven by higher domestic sales realizations and moderately higher fee harvest and domestic sales volumes[15, 17] - Southern Timberlands Adjusted EBITDA decreased slightly to $71 million in Q1 2025 from $74 million in Q4 2024, with comparable fee harvest volumes and sales realizations[15, 17] Financial Position - The company's ending cash balance decreased to $560 million in Q1 2025 from $684 million in Q4 2024[45] - Total debt increased to $5.167 billion in Q1 2025 from $5.076 billion in Q4 2024[45]

COLGATE-PALMOLIVE COMPANY 1Q 2025 EARNINGS PRESENTATION APRIL 25, 2025 April 2025 Notice for Investor Presentation Please review the following first quarter 2025 earnings presentation in conjunction with our first quarter 2025 earnings press release, our first quarter 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our website at www.colgatepalmolive.com/in ...

First Quarter 2025 Results April 25, 2025 Our forward‐looking statements are subject to, among others, the following principal risks and uncertainties: general economic conditions and trends, either nationally or locally; conditions in the securities, credit and financial markets; changes in interest rates; changes in deposit flows, and in the demand for deposit, loan, and investment products and other financial services; changes in real estate values; changes in the quality or composition of our loan or in ...

Q1 2025 Earnings Earnings Presentation April 25, 2025 Disclaimer Forward-looking statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking s ...

First Quarter 2025 Financial Results April 25, 2025 1 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements, including, without limitation, those related to: strengthening demand in our CCS segment, demand environment and customer forecasts, our anticipated financial and/or operational results, guidance and outlook, including statements under the headings "Q2 2025 Guidance", "Q2 2025 Non-GAAP Tax Rate Estimate", "Q2 2025 End Market Revenue Outlook", "2025 ...

Welcome to R&D Day April 24, 2025 © 2025 Esperion Therapeutics, Inc. All rights reserved. Forward-looking Statements & Disclosures This investor presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding marketing strategy and commercialization plans, current and planned operational expenses, future operations, commercial products, clinical development, plans for potential future product candidates, fin ...

BeFra Q1 2025 Earnings Results April 2025 Q1 2025 Highlights: BeFra Group Net revenue decreased 2.9%, driven by a decline in sales on Betterware Mexico of 9.8% and softer than expected, yet positive growth in Jafra Mexico of 1.1%, tempered by weak consumer spending amid macroeconomic uncertainty. Gross Margin declined 353 basis points mainly due to margin pressures in Betterware Mexico and Jafra Mexico from FX pressures resulting in higher costs with the Mexican Peso depreciating around 20% on a yearly basi ...